InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Galovan Scott Michael, Chief Financial Officer. Insider active across 1 company, notably Avanos Medical, INC.. Cumulatively, 12 reports have been published. Activity tracked since 6 March 2026. The latest transaction was filed on 27 July 2026 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Galovan Scott Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
135,596 shares@ US$25.00Common StockSEC:0001606498-26-000111:0
96,121 shares0Common StockSEC:0001606498-26-000111:1
96,121 shares@ US$25.00Common StockSEC:0001606498-26-000111:2
4,228 shares@ US$24.640.0087% mcap39.7% of flowCommon StockSEC:0001606498-26-000059:0
29,481 shares0Common StockSEC:0001606498-26-000040:0
29,481 shares0Common StockSEC:0001606498-26-000031:0
29,481 shares0Common StockSEC:0001606498-26-000027:0
1,119 shares@ US$13.295.4% of flowCommon StockSEC:0001606498-26-000014:0
5,907 shares@ US$13.790.0061% mcap52.0% of flowCommon StockSEC:0001606498-26-000010:0
2,356 shares@ US$13.790.0024% mcap20.7% of flowCommon StockSEC:0001606498-26-000010:1
1,057 shares@ US$13.790.0011% mcap9.3% of flowCommon StockSEC:0001606498-26-000010:2
2,041 shares@ US$13.790.0021% mcap18.0% of flowCommon StockSEC:0001606498-26-000010:3
12 of 12 declarations
About Galovan Scott Michael
Scott Michael Galovan is Chief Financial Officer at Avanos Medical, Inc. He is responsible for the financial management of the company, including budgeting and financial analysis. With a strong background in corporate finance, Scott plays a key role in financial strategy and decision-making. His expertise is essential in ensuring the financial health of Avanos Medical, Inc.
